The association between population-based treatment guidelines and adjuvant therapy for node negative breast cancer

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1534-1542

  Sawka, C ^a,b,c,d   Olivotto, I ^e,f   Coldman, A ^e,f   Goel, V ^c,d,g   Holowaty, E ^g,h   Hislop, T G ^e,f   Allan, Sharon ⁱ   Kula, Josephine ⁱ   McGregor, Gregory ⁱ   Plenderleith, Ian ⁱ   Tompkins, Beth ⁱ   Trevisan, Caroline ⁱ   Dale, Darlene ⁱ   Kirkbride, Peter ⁱ   McCready, David ⁱ   Pritchard, Kathleen ⁱ   Radolovich, Carmen ⁱ  

^a UNIVERSITY OF TORONTO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h Ontario Cancer Registry   (Canada)

ⁱ NONE

Author keywords

Adjuvant therapy; Breast cancer; Treatment guidelines

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 8244263614     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.262     Document Type: Article

References (37)

1. Audet AM, Greenfield S and Field M (1990) Medical practice guidelines: current activities and future directions. Ann Intern Med 13: 709-714
2. Breiman L, Friedman J, Olshen R, Stone CJ (1994) Classification and Regression Trees. Breiman L, Friedman J and Olshen R (eds). Wadsworth: Belmont
3. Browman GP, Levine MN, Mohide E, Hayward RS, Pritchard KI, Gafni A and Laupacis A (1995) The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 13: 502-512
4. Canadian Hospital Association (1991) Canadian Hospital Directory 1991-1992 Canadian Hospital Association: Ottawa
5. Canadian Medical Directory (37th edn) (1991) Southam Business Communications, Don Mills
6. Committee to Advise the Public Health Service on Clinical Practice Guidelines, Institute of Medicine (1990) Clinical practice guidelines: directions for a new program. Natl Acad Pr 38: Washington
7. CRC Adjuvant Breast Trial Working Party (1988) Cyclophosphamide und tamoxifen as adjuvant therapies in the management of breast cancer. Br J Cancer 57: 604-607
8. Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1-5, 71-85
9. Fisher B, Redmond C, Fisher ER and Caplan R (1988) Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6: 1076-1087
10. Fisher B, Redmond C, Dimitrov NV, Bowman D, Legualt-Poisson S, Wickerham DL, Wolmark N, Fisher ER, Margolese R, Sutherland C, Glass A, Foster R, Caplan R, Abramson N, Allegra JC, Beazley R, Cruz AB, Elias GE, Feldman MI, Henderson C, Levick SH, Oishi R, Poisson R, Robidoux A, Rosen R, Shah NM, Shibata H, State D, Terz J, Welling R and Wozniak T (1989a) A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320: 473-478
11. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickely L, Ketner M, Abramson N, Allegra JC, Beazley R, Berry J, Boatman KK, Bowman D, Carmichael D, Cruz AB, Davies R, Deckers P, Desser R, Economou S, Elias EG, Foster RS, Frazier TG, Glass AG, Jochimsen P, Jubelirer S, Kardinal CG, Keyserlingk JR, Lerner HJ, Levick SN, Mahoney L, Mowry P, Nicola M, Oishi R, Pasquale D, Perrault D, Peters G, Pugh R, Robert N, Robidoux A, Shibata H, Spector J, Sponzo R, Sterchi JM, Sutherland CM, Terz J, Thiessen R, Thirlwell M, Welling R, Wold H and Wozniak T (1989b) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479-484
12. Ford LG, Hunter CP, Diehr P, Frelick RW and Yates J (1987) Effects of patient management guidelines on physician practice patterns: the Community Hospital Oncology Program experience. J Clin Oncol 5: 504-511
13. Glick J, Gelber R, Goldhirsch A and Senn HJ (1993) Adjuvant therapy of primary breast cancer: closing summary. In: Adjuvant Therapy of Breast Cancer IV. Senn HJ, Gelber R, Goldhirsch A and Thurlimann B (eds). pp. 289-300. Springer: Berlin
14. Gregorio DI, Strelez LA and Sporn JA (1990) Attitudes and practices regarding adjuvant chemotherapy in node-negative breast cancer. J Cancer Educ 5: 187-192
15. Grilli R, Apolone G, Marsoni S, Nicolucci A, Xola P and Liberati A (1991) The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Medical Care 29: 50-63
16. Grimshaw J, Freemantle N, Wallace S, Russell I, Hurwitz B, Watt I, Long A and Sheldon T (1995) Developing and implementing clinical practice guidelines. Qualify in Health Care 4: 5-64
17. Henderson IC (1991) Adjuvant systemic therapy of early breast cancer. In Breast Diseases, 2nd edn. Harris J, Hellman S, Henderson IC und Kinne D (eds). pp. 427-486. JB Lippincott: Philadelphia.
18. Johnson TP Ford L, Warnecke RB, Nayfield SG, Kaluzny A, Cutter G, Gillings D, Sondik E and Ozer H (1994) Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns. J Clin Oncol 12: 1783-1788
19. Kanouse DE and Jacoby I (1988) When does information change practitioners' behavior? Intl J Technol Assess Health Care 4: 27-33
20. Kelly JT and Toepp MC (1992) Practice parameters: development, evaluation, dissemination, and implementation. Q Rev Bull 18: 405-409
21. Ludwig Breast Cancer Study Group (1989) Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320: 491-496
22. McBride M and Donaldson L (1987) Ascertainment and data collection for a cancer registry. British Columbia Med J 29: 30-40
23. McCarthy M and Bore J (1991) Treatment of breast cancer in two teaching hospitals: a comparison with consensus guidelines. Eur J Cancer 5: 579-582
24. McGuire WL (1489) Adjuvant therapy of node-negative breast cancer (editorial). N Engl J Med 320: 525-527
25. McGuire W and Clark G (1992) Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326: 1756-1761
26. McPhee S, Richard R and Solkowitz S (1986) Performance of cancer screening in a university general internal medicine practice: comparison with the American Cancer Society guidelines. J Gen Intern Med 1: 275-281
27. Mansour EG, Gray R, Shatila AH, Osbourne CK, Tormey DC, Gilchrist KW, Cooper MR and Falkson G (1989) Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: an Intergroup study. N Engl J Med 320: 485-190
28. Mittman B and Siu A (1992) Changing provider behavior: applying research on outcomes and effectiveness in health care. In Improving Health Policy and Management, Shortell S and Reinhardt U (eds). pp. 95-226. Health Administration Press: Ann Arbor
29. National Cancer Institute of Canada (1995) Canadian Cancer Statistic 1995. National Cancer Institute of Canada, Toronto.
30. Olivotto I, Bajdik C, Plenderleith I, Coppin CM, Gelmon KA, Jackson SM, Ragaz J, Wilson KS and Worth A (1994) Adjuvant systemic therapy and survival from breast cancer. N Engl J Med 330: 805-810
31. Olivotto IA, Coldman AJ, Hislop TG, Trevisan CH, Goel V and Sawka C (1997) Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol 15: 216-222
32. Robles SC, Marrett LD, Clarke EA and Risch HA (1988) An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 41: 495-501
33. Scottish Cancer Trials Office (1987) Adjuvant tamoxifen in the management of operable breast cancer. Lancet 2: 171-175
34. Shapiro DW, Lasker RD, Bindman AH and Lee PR (1993) Containing costs while improving quality of care: the role of profiling and practice guidelines. Annu Rev Publ Health 14: 219-241
35. Statistics Canada (1992) 1991 Census of Canada. Supply and Services Canada: Ottawa.
36. Studnicki J, Schapira DV, Bradham DD, Clark RA and Jarrett A (1993) Response to the National Cancer Institute Clinical Alert. The effect ot practice guidelines on two hospitals in the same medical community. Cancer 72: 2986-2992
37. Wilkins R (1993) Use of postal codes and analysis of health data. Health Reports 5: 157-177